Literature DB >> 15069079

Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6. Roles for multiple phosphorylation sites and Stat6 function.

Yuling Wang1, Maria Grazia Malabarba, Zsuzsanna S Nagy, Robert A Kirken.   

Abstract

Lymphokines interleukin-4 (IL4) and IL13 exert overlapping biological activities via the shared use of the IL4 receptor alpha-chain and signal transducer and activator of transcription 6 (Stat6). Stat6 is critical for T-helper 2 cell differentiation, B-cell Ig class switch, and allergic diseases; thus, understanding its regulation is of central importance. Phosphorylation is crucial for Stat activity. Whereas Stat6 is phosphorylated on Tyr(641), less is known about serine or threonine. We demonstrate in primary human T-cells (>95% CD3+) that IL4 and for the first time IL13 induce Stat6 serine but not threonine phosphorylation that closely paralleled early IL4 receptor alpha-chain activation (10 min). Stat6 uniquely fails to share a positionally conserved Stat serine phosphorylation sequence; however, known phosphoacceptor sites are proline-flanked. Alanine substitutions of these conserved residues revealed that the transactivation domain, which localized Ser(756) but not Ser(827) or Ser(176), is the IL4-regulated site based on phosphoamino acid analysis. Tyr(641) was dispensable for IL4-mediated serine phosphorylation, suggesting that dimerization is not preconditional. Only Stat6 Y641F variant showed a significant effect on IL4-inducible Cepsilon DNA-binding and reporter gene expression. Lastly, recent work has shown that protein phosphatase 2A negatively regulates Stat6. We propose this target residue(s) is distinct from Ser(756) and may be proximal to Tyr(641) at Thr(645), a residue conserved only among Stat6 members. The phosphomimic variants T645E or T645D ablated Stat6 activation, whereas polar uncharged substitutions (Gln or Asn) and additional mutants (Ala, Val, or Phe) showed no effect. These findings suggest that Stat6 has mechanisms of regulation distinct from other Stats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15069079     DOI: 10.1074/jbc.M313668200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Authors:  Blanca E Ruiz-Medina; Jeremy A Ross; Robert A Kirken
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

2.  Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Authors:  Abhisek Mitra; Jeremy A Ross; Georgialina Rodriguez; Zsuzsanna S Nagy; Harry L Wilson; Robert A Kirken
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

Review 3.  Transcriptional regulation by STAT6.

Authors:  Shreevrat Goenka; Mark H Kaplan
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

4.  Deactivation of STAT6 through serine 707 phosphorylation by JNK.

Authors:  Takashi Shirakawa; Yoshinori Kawazoe; Tomoko Tsujikawa; Dongju Jung; Shin-ichi Sato; Motonari Uesugi
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 5.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

Review 6.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

7.  Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.

Authors:  Jeremy A Ross; Hanyin Cheng; Zsuzsanna S Nagy; Jeffrey A Frost; Robert A Kirken
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

Review 8.  Interleukin-13: prospects for new treatments.

Authors:  C E Brightling; S Saha; F Hollins
Journal:  Clin Exp Allergy       Date:  2009-10-30       Impact factor: 5.018

9.  Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter.

Authors:  Kathryn E Sheldon; Harish Shandilya; Diane Kepka-Lenhart; Mirjana Poljakovic; Arundhati Ghosh; Sidney M Morris
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

10.  An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion.

Authors:  Hiroya Miyamoto; Eri Katsuyama; Yoshiteru Miyauchi; Hiroko Hoshi; Kana Miyamoto; Yuiko Sato; Tami Kobayashi; Ryotaro Iwasaki; Shigeyuki Yoshida; Tomoaki Mori; Hiroya Kanagawa; Atsuhiro Fujie; Wu Hao; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.